| Lung Diagnosis Group | Year | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | |
| Total | 2,429 | 2,484 | 2,417 | 2,281 | 2,315 | 2,163 | 1,052 | 1,031 | 1,006 | 1,089 |
| Group A: Obstructive Lung Disease | 1,157 | 1,134 | 1,058 | 1,045 | 990 | 916 | 527 | 501 | 505 | 548 |
| Group B: Pulmonary Vascular Disease | 268 | 288 | 291 | 235 | 227 | 198 | 90 | 77 | 52 | 60 |
| Group C: Cystic Fibrosis or Immunodef. Disorders | 422 | 423 | 416 | 359 | 360 | 329 | 156 | 152 | 140 | 127 |
| Group D: Restrictive Lung Disease | 493 | 557 | 581 | 572 | 672 | 663 | 231 | 281 | 278 | 340 |
| Group E: Age Less Than 12 | 40 | 52 | 38 | 35 | 38 | 51 | 45 | 19 | 28 | 13 |
| Other Diagnosis | 49 | 30 | 33 | 35 | 28 | 6 | 3 | 1 | 3 | 1 |
| Total (%) | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Group A: Obstructive Lung Disease | 47.6% | 45.7% | 43.8% | 45.8% | 42.8% | 42.3% | 50.1% | 48.6% | 50.2% | 50.3% |
| Group B: Pulmonary Vascular Disease | 11.0% | 11.6% | 12.0% | 10.3% | 9.8% | 9.2% | 8.6% | 7.5% | 5.2% | 5.5% |
| Group C: Cystic Fibrosis or Immunodef. Disorders | 17.4% | 17.0% | 17.2% | 15.7% | 15.6% | 15.2% | 14.8% | 14.7% | 13.9% | 11.7% |
| Group D: Restrictive Lung Disease | 20.3% | 22.4% | 24.0% | 25.1% | 29.0% | 30.7% | 22.0% | 27.3% | 27.6% | 31.2% |
| Group E: Age Less Than 12 | 1.6% | 2.1% | 1.6% | 1.5% | 1.6% | 2.4% | 4.3% | 1.8% | 2.8% | 1.2% |
| Other Diagnosis | 2.0% | 1.2% | 1.4% | 1.5% | 1.2% | 0.3% | 0.3% | 0.1% | 0.3% | 0.1% |